Home > > > Report Detail

Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 30-Nov-2022
No. of pages: 114
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Gastroesophageal Reflux Disease (GERD) Drugs and Devices companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Gastroesophageal Reflux Disease (GERD) Drugs and Devices market. Further, it explains the major drivers and regional dynamics of the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- AstraZeneca, Plc.

- Addex Therapeutics

- Takeda Pharmaceutical Company Limited

- Rottapharm (Meda AB)

- Pfizer, Inc.

- Eisai Co. Ltd.

- The Procter & Gamble Company

- Mederi Therapeutics

- Aros Pharma

- Torax Medical, Inc.

- BD

- EndoGastric Solutions

- Medigus Ltd.

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Type

- Medication

- Minimally Invasive Surgery

- Invasive Surgery

Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Application

- Heartburn

- Acid reflux disorders

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Gastroesophageal Reflux Disease (GERD) Drugs and Devices market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Gastroesophageal Reflux Disease (GERD) Drugs and Devices, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gastroesophageal Reflux Disease (GERD) Drugs and Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastroesophageal Reflux Disease (GERD) Drugs and Devices revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Gastroesophageal Reflux Disease (GERD) Drugs and Devices revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited, Rottapharm (Meda AB), Pfizer, Inc., Eisai Co. Ltd., The Procter & Gamble Company, Mederi Therapeutics and Aros Pharma, etc.

Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Medication
1.2.3 Minimally Invasive Surgery
1.2.4 Invasive Surgery
1.3 Market by Application
1.3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Heartburn
1.3.3 Acid reflux disorders
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2017-2028)
2.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2017-2022)
2.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2023-2028)
2.5 Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Countries Ranking by Market Size
3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Competitive by Company
3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Players
3.1.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Players (2017-2022)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Players (2017-2022)
3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue
3.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Ratio
3.4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2021
3.5 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Players Head office and Area Served
3.6 Key Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Solution and Service
3.7 Date of Enter into Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data by Type
4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Revenue by Type (2017-2022)
4.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Revenue by Type (2023-2028)
5 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data by Application
5.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Application (2017-2022)
5.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Company (2020-2022)
6.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2017-2028)
6.3 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2017-2028)
6.4 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Company (2020-2022)
7.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2017-2028)
7.3 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2017-2028)
7.4 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Company (2020-2022)
8.2 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2017-2028)
8.3 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2017-2028)
8.4 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Company (2020-2022)
9.2 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2017-2028)
9.3 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2017-2028)
9.4 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Company (2020-2022)
10.2 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2017-2028)
10.3 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2017-2028)
10.4 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 AstraZeneca, Plc.
11.1.1 AstraZeneca, Plc. Company Details
11.1.2 AstraZeneca, Plc. Business Overview
11.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.1.4 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.1.5 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
11.1.6 AstraZeneca, Plc. Recent Developments
11.2 Addex Therapeutics
11.2.1 Addex Therapeutics Company Details
11.2.2 Addex Therapeutics Business Overview
11.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.2.4 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.2.5 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
11.2.6 Addex Therapeutics Recent Developments
11.3 Takeda Pharmaceutical Company Limited
11.3.1 Takeda Pharmaceutical Company Limited Company Details
11.3.2 Takeda Pharmaceutical Company Limited Business Overview
11.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.3.4 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.3.5 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
11.3.6 Takeda Pharmaceutical Company Limited Recent Developments
11.4 Rottapharm (Meda AB)
11.4.1 Rottapharm (Meda AB) Company Details
11.4.2 Rottapharm (Meda AB) Business Overview
11.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.4.4 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.4.5 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
11.4.6 Rottapharm (Meda AB) Recent Developments
11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Company Details
11.5.2 Pfizer, Inc. Business Overview
11.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.5.4 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.5.5 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
11.5.6 Pfizer, Inc. Recent Developments
11.6 Eisai Co. Ltd.
11.6.1 Eisai Co. Ltd. Company Details
11.6.2 Eisai Co. Ltd. Business Overview
11.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.6.4 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.6.5 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
11.6.6 Eisai Co. Ltd. Recent Developments
11.7 The Procter & Gamble Company
11.7.1 The Procter & Gamble Company Company Details
11.7.2 The Procter & Gamble Company Business Overview
11.7.3 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.7.4 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.7.5 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
11.7.6 The Procter & Gamble Company Recent Developments
11.8 Mederi Therapeutics
11.8.1 Mederi Therapeutics Company Details
11.8.2 Mederi Therapeutics Business Overview
11.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.8.4 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.8.5 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
11.8.6 Mederi Therapeutics Recent Developments
11.9 Aros Pharma
11.9.1 Aros Pharma Company Details
11.9.2 Aros Pharma Business Overview
11.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.9.4 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.9.5 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
11.9.6 Aros Pharma Recent Developments
11.10 Torax Medical, Inc.
11.10.1 Torax Medical, Inc. Company Details
11.10.2 Torax Medical, Inc. Business Overview
11.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.10.4 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.10.5 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
11.10.6 Torax Medical, Inc. Recent Developments
11.11 BD
11.11.1 BD Company Details
11.11.2 BD Business Overview
11.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.11.4 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.11.5 BD Recent Developments
11.12 EndoGastric Solutions
11.12.1 EndoGastric Solutions Company Details
11.12.2 EndoGastric Solutions Business Overview
11.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.12.4 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.12.5 EndoGastric Solutions Recent Developments
11.13 Medigus Ltd.
11.13.1 Medigus Ltd. Company Details
11.13.2 Medigus Ltd. Business Overview
11.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Products and Services
11.13.4 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022)
11.13.5 Medigus Ltd. Recent Developments
12 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Dynamics
12.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Trends
12.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
12.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
12.4 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Medication
Table 3. Key Players of Minimally Invasive Surgery
Table 4. Key Players of Invasive Surgery
Table 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Region (2017-2022)
Table 9. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Players (2017-2022)
Table 11. Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices as of 2021)
Table 12. Ranking of Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Type (2017-2022)
Table 20. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Type (2023-2028)
Table 22. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Application (2017-2022)
Table 24. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Application (2023-2028)
Table 26. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
Table 61. AstraZeneca, Plc. Company Details
Table 62. AstraZeneca, Plc. Business Overview
Table 63. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 64. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 65. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 66. AstraZeneca, Plc. Recent Developments
Table 67. Addex Therapeutics Company Details
Table 68. Addex Therapeutics Business Overview
Table 69. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 70. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 71. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 72. Addex Therapeutics Recent Developments
Table 73. Takeda Pharmaceutical Company Limited Company Details
Table 74. Takeda Pharmaceutical Company Limited Business Overview
Table 75. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 76. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 77. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 78. Takeda Pharmaceutical Company Limited Recent Developments
Table 79. Rottapharm (Meda AB) Company Details
Table 80. Rottapharm (Meda AB) Business Overview
Table 81. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 82. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 83. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 84. Rottapharm (Meda AB) Recent Developments
Table 85. Pfizer, Inc. Company Details
Table 86. Pfizer, Inc. Business Overview
Table 87. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 88. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 89. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 90. Pfizer, Inc. Recent Developments
Table 91. Eisai Co. Ltd. Company Details
Table 92. Eisai Co. Ltd. Business Overview
Table 93. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 94. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 95. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 96. Eisai Co. Ltd. Recent Developments
Table 97. The Procter & Gamble Company Company Details
Table 98. The Procter & Gamble Company Business Overview
Table 99. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 100. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 101. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 102. The Procter & Gamble Company Recent Developments
Table 103. Mederi Therapeutics Company Details
Table 104. Mederi Therapeutics Business Overview
Table 105. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 106. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 107. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 108. Mederi Therapeutics Recent Developments
Table 109. Aros Pharma Company Details
Table 110. Aros Pharma Business Overview
Table 111. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 112. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 113. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 114. Aros Pharma Recent Developments
Table 115. Torax Medical, Inc. Company Details
Table 116. Torax Medical, Inc. Business Overview
Table 117. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 118. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 119. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 120. Torax Medical, Inc. Recent Developments
Table 121. BD Company Details
Table 122. BD Business Overview
Table 123. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 124. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 125. BD Recent Developments
Table 126. EndoGastric Solutions Company Details
Table 127. EndoGastric Solutions Business Overview
Table 128. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 129. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 130. EndoGastric Solutions Recent Developments
Table 131. Medigus Ltd. Company Details
Table 132. Medigus Ltd. Business Overview
Table 133. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Services
Table 134. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2017-2022) & (US$ Million)
Table 135. Medigus Ltd. Recent Developments
Table 136. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Trends
Table 137. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
Table 138. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
Table 139. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Type: 2021 VS 2028
Figure 2. Medication Features
Figure 3. Minimally Invasive Surgery Features
Figure 4. Invasive Surgery Features
Figure 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application: 2021 VS 2028
Figure 6. Heartburn Case Studies
Figure 7. Acid reflux disorders Case Studies
Figure 8. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Report Years Considered
Figure 9. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size 2017-2028 (US$ Million)
Figure 11. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region: 2021 VS 2028
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Region in 2017 VS 2022
Figure 13. Global Top 10 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Countries Ranking by Market Size (US$ Million) in 2021
Figure 14. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Players in 2021
Figure 15. Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2021
Figure 17. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Company in 2021
Figure 18. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Type (2017-2028)
Figure 19. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Application (2017-2028)
Figure 20. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Country (2017-2028)
Figure 21. U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (2017-2028) & (US$ Million)
Figure 22. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (2017-2028) & (US$ Million)
Figure 23. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Company in 2021
Figure 24. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Type (2017-2028)
Figure 25. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Application (2017-2028)
Figure 26. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Country (2017-2028)
Figure 27. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (2017-2028) & (US$ Million)
Figure 28. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (2017-2028) & (US$ Million)
Figure 29. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (2017-2028) & (US$ Million)
Figure 30. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (2017-2028) & (US$ Million)
Figure 31. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Device
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs